Goldman Sachs’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
Other funds holding TENX
Goldman Sachs's TENX Position: Q3 2026 in Review
Goldman Sachs increased its Tenax Therapeutics (TENX) stake by 128% in Q3 2026, buying an estimated $2.65M and bringing the position to 627,023 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #5103.
Goldman Sachs first reported a position in TENX in Q3 2014 and has held it in 12 quarters since. The position peaked at $4M in Q2 2026. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.
- Goldman Sachs held 627,023 shares of Tenax Therapeutics worth $1.19M as of Q3 2026.
- Goldman Sachs bought 352,077 Tenax Therapeutics shares in Q3 2026, an estimated $2.65M.
- Tenax Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #5103 holding.
- Goldman Sachs first reported a position in Tenax Therapeutics in Q3 2014 and has held it in 12 quarters since.
- Goldman Sachs's Tenax Therapeutics position peaked at $4M in Q2 2026.
- 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.